Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 117079
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.117079
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.117079
Figure 1 Of 350 patients screened for eligibility, 30 were excluded due to fever duration > 7 days (n = 14), identified non-dengue etiology at presentation (n = 9), or refusal to provide consent (n = 7).
The remaining 320 eligible patients were enrolled and underwent NS1/IgM/IgG testing. A quality-assurance subset (n = 32) underwent enzyme-linked immunosorbent assay confirmation. ELISA: Enzyme-linked immunosorbent assay; QA: Quality assurance.
- Citation: Dhotre SV, Ghatole MP, Dhotre PS, Kashetty VA, Nagoba BS. Seroprevalence and clinical profile of dengue infection among acute febrile patients at a rural tertiary care hospital. World J Virol 2026; 15(1): 117079
- URL: https://www.wjgnet.com/2220-3249/full/v15/i1/117079.htm
- DOI: https://dx.doi.org/10.5501/wjv.v15.i1.117079
